In recent years, the incidence of ischemic stroke has increased everywhere. This fact is explained by the increase in the number of elderly people and the prevalence of risk factors for stroke, such as arterial hypertension, diabetes, obesity, heart disease, etc., more than 80% of survivors are disabled. To date, neuroprotective therapy is the most important treatment in the treatment of this disease, and this article really describes its improving properties.
In 25% of cases the patients with ischemic diseases of the retina have hemodynamically significant atherosclerotic
lesions of carotid system vessels. The patients who in addition to the basic therapy received the calcium channel blocker Tab.
Nimotopi 30mg x 3 t/d, demonstrated better and more stable results of visual functions, general rehabilitation in remote period as compared to the control group